Samsung is looking to launch its flagship Galaxy S21 smartphones a month earlier than planned next year to grab Huawei's market share and fend off competition from Apple Inc.
The new Galaxy S21 may come out as early as late January next year, rather than in March when Samsung previously launched its flagship S20 phone this year.
Samsung shipped 59 percent less Galaxy S20 5G series handsets in the US in the second quarter than its previous flagship model in the same period last year.
In contrast, Apple's shipment of its flagship iPhone 11 increased by 15 percent than its iPhone XR in 2019.
Samsung lost its No.1 position to Huawei in the second quarter but regained it in the third due in part to the US restrictions on the Chinese smartphone maker.
According to an industry insider, Huawei’s stockpiles smartphone chips may run out by early next year.
However, other Chinese brands such as Xiaomi and Oppo are vying for Huawei’s previous market share.
The launch of Apple's iPhone series is in October, about a month later than usual.


Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence 



